MedPath

ALCON LABORATORIES (AUSTRALIA) PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

9

TGA:9

Drug Approvals

SYSTANE RED EYES naphazoline hydrochloride 1 mg/mL eye drops bottle (286697)

Product Name
SYSTANE RED EYES naphazoline hydrochloride 1 mg/mL eye drops bottle
Approval Date
Mar 14, 2017
TGA

FLUORESCITE fluorescein 10% 500mg/5mL (as sodium) injection vial (124267)

Product Name
FLUORESCITE fluorescein 10% 500mg/5mL (as sodium) injection vial
Approval Date
Apr 12, 2006
TGA

NAPHCON-A eye drops bottle (47652)

Product Name
NAPHCON-A eye drops bottle
Approval Date
Jan 24, 1994
TGA

MIOSTAT carbachol 0.15mg/1.5mL intraocular injection vial (40624)

Product Name
MIOSTAT carbachol 0.15mg/1.5mL intraocular injection
Approval Date
Jun 29, 1992
TGA

CYCLOGYL cyclopentolate hydrochloride 1% eye drops bottle (25273)

Product Name
CYCLOGYL cyclopentolate hydrochloride 1% eye drops bottle
Approval Date
Oct 15, 1991
TGA

MYDRIACYL tropicamide 1% eye drops bottle (25357)

Product Name
MYDRIACYL tropicamide 1% eye drops bottle
Approval Date
Oct 15, 1991
TGA

MYDRIACYL tropicamide 0.5% eye drops bottle (25356)

Product Name
MYDRIACYL tropicamide 0.5% eye drops bottle
Approval Date
Oct 15, 1991
TGA

ALCAINE proxymetacaine hydrochloride 0.5% eye drops bottle (24299)

Product Name
ALCAINE proxymetacaine hydrochloride 0.5% eye drops bottle
Approval Date
Oct 15, 1991
TGA

NAPHCON FORTE naphazoline hydrochloride 1mg/mL eye drops bottle (10231)

Product Name
NAPHCON FORTE naphazoline hydrochloride 1mg/mL eye drops bottle
Approval Date
Jul 4, 1991
TGA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.